Executions are on hold in several states as supplies of key drug used in lethal injections have dried up, and the maker of the drug has a chance to stand up against what it sees as a twisted use of its product.

Hospira, the manufacturer of lethal-injection drug sodium thiopental, has said it does not support the drug's use in lethal injections.

Send a letter to Hospira CEO Christopher Begley urging him to use this opportunity to announce that his company will no longer supply the drug to state corrections departments for use in lethal injections.